From a molecular laboratory viewpoint, Relafen 750 ( Naproxen Sodium ) presents a compelling case. Its mechanism of action primarily involves inhibiting cyclooxygenase enzymes , specifically COX-1 and COX-2, thereby reducing prostaglandin production . This contributes to decreased inflammation and fever . The drug's relatively long half-life and sp